H.K. Johansen, K. Kjeldsen, N. Høiby

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Philippe Brouqui, Didier Raoult, Jean Marc Durand

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

Herpes zoster in non-hospitalized children

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Pseudomonas aeruginosa diversity in distinct paediatric patient groups

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species Jacques Dubois, Claude St-Pierre Clinical.

Escherichia coli native valve endocarditis

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Vector control: a cornerstone in the malaria elimination campaign

L. Gatta, C. Ricci, A. Tampieri, D. Vaira

Infective endocarditis due to Propionibacterium species

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

Development of antimicrobial resistance in Staphylococcus lugdunensis during treatment—report of a case of bacterial arthritis, vertebral osteomyelitis.

F. Grill, P. Muñoz, R. Jofre, E. Bouza

Laboratory diagnosis and biosafety issues of biological warfare agents

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections P.S. Hicks, B.

Uncommon opportunistic fungi: new nosocomial threats

Multi-valvular endocarditis

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin King A. , Bathgate.

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

Campylobacter fetus pericarditis in a patient with β-thalassemia: case report and review of the literature S.S. Kanj, G.F. Araj, A. Taher, L.B. Reller

B.J.A. Rijnders, E. van Wijngaerden, J. van Eldere, W.E. Peetermans

Community-acquired pneumonia: epidemiologic and clinical consideration

Training in infectious diseases and tropical medicine in Britain

J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A

Fibronectin concentrations in catheter sepsis

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Evaluation of the performance of the Helico Blot 2

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Are we losing the fight against malaria one more time?

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

Typing of Clostridium difficile

New patterns of HIV-1 resistance during HAART

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Localized Mycobacterium avium complex infection in a patient on HAART

The future of diagnostic bacteriology

Presentation transcript:

Pseudomonas mendocina as a cause of chronic infective endocarditis in a patient with situs inversus H.K. Johansen, K. Kjeldsen, N. Høiby Clinical Microbiology and Infection Volume 7, Issue 11, Pages 650-652 (November 2001) DOI: 10.1046/j.1198-743x.2001.00331.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Crossed immunoelectrophoresis of 2 μL of sonicated water-soluble antigens from the patient's own P mendocina isolate against 300 μL of serum from the patient with tricuspid valve endocarditis. Size of the plate 5 × 5 cm. (1) Dimension electrophoresis, anode to the right. (2) Dimension electrophoresis, anode to the top. (a) 16 precipitins from 1994. (b) 24 precipitins from 1999. Normal: 0–1 precipitates. Clinical Microbiology and Infection 2001 7, 650-652DOI: (10.1046/j.1198-743x.2001.00331.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions